(January 12, 2021, 1:52 PM EST) -- ALEXANDRIA, Va. — The maker of an antibody cocktail that recently won emergency use authorization for the treatment of COVID-19 is being challenged on a different front before the Patent Trial...
Regeneron Patent Targeted In New Post-Grant Review Petition
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login